Requirement of longer term antiviral therapy in patients with cytomegalovirus anterior uveitis with corneal endothelial cell damage
Clinical Ophthalmology Aug 01, 2018
Harada Y, et al. - Authors gauged the effectiveness of therapy in patients with cytomegalovirus (CMV) anterior uveitis. Findings suggested a likeliness of the patients with corneal endothelial cell loss to require longer-term antiviral therapy than those without endothelial damage. Moreover, the detection of CMV DNA in aqueous humor by polymerase chain reaction was required by the definitive diagnosis of CMV anterior uveitis, one-fifth of patients in the present study tested negative on initial examination.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries